News & Events about Vertex Pharmaceuticals Incorporated.
Stock Options Channel
1month ago
Investors in Vertex Pharmaceuticals, Inc. (VRTX) saw new options begin trading today, for the June 23rd expiration...
Fool.com Headlines
1month ago
Vertex dominates the cystic fibrosis market today.Vertex Pharmaceuticals (NASDAQ: VRTX) is the global leader in cystic fibrosis (CF) treatment. The company is known for its combination therapies targeting a defective protein that causes the disease's devastating symptoms.But one possible threat to ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved the expanded use of TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis (CF) ages 2 through 5 years who have at least one F508del...
Fool.com Headlines
1month ago
These companies are top players in their fields.When you think of healthcare stocks, you may think of steady growth and security. That's true in many instances. But healthcare players -- even some with that steady growth and security -- can also offer you a good deal of growth. And this may help you...
VERTEX DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Vertex To Contact Him Directly To Discuss Their Options VERTEX DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered...